The 20 Best Spinocerebellar Ataxia Type 5 Doctors Near Me in Michigan, US

Henry L. Paulson, M.D., Ph.D., is the Lucile Groff Professor of Neurology for Alzheimer's Disease and Related Disorders in the Department of Neurology at the University of Michigan. Dr. Paulson joined the U-M faculty in 2007, and he currently directs the Michigan Alzheimer’s Disease Center (MADC) and co-direct the U-M Protein Folding Diseases Initiative.Dr. Paulson received his medical degree and doctorate in Cell Biology from Yale University in 1990. He then completed a neurology residency and neurogenetics/movement disorders fellowships at the University of Pennsylvania. In 1997, he joined the Neurology faculty at the University of Iowa, where he remained until 2007.Dr. Paulson's research and clinical interests concern the causes and treatment of age-related neurodegenerative diseases, with an emphasis on polyglutamine diseases, Alzheimer's disease and frontotemporal dementia. In 1997, his lab described abnormal protein aggregates in the polyglutamine diseases, which now are recognized as a pathological hallmark in this important class of inherited diseases. Using test tube, cell-based and animal models, he has contributed to advances in the understanding of various neurodegenerative diseases. His lab also has helped pioneer the use of gene silencing methods as potential therapy for the many neurological disorders caused by toxic mutant genes.Nationally, Dr. Paulson has directed popular courses at the American Academy of Neurology meetings, serves on the scientific advisory boards of numerous disease-related national organizations, and is past Chair of the Board of Scientific Counselors at the National Institute for Neurological Disorders and Stroke at the National Institutes of Health.Among his awards, Dr. Paulson is an Ellison Medical Foundation New Scholar in Aging, a semifinalist for the W.M. Keck Foundation Young Scholars in Medical Research, and a recipient of the Paul Beeson Physician Faculty Scholar in Aging Award from the American Federation for Aging Research. Dr. Paulson is rated as a Distinguished provider by MediFind in the treatment of Spinocerebellar Ataxia Type 5. He is also highly rated in 41 other conditions, according to our data. His clinical expertise encompasses Spinocerebellar Ataxia Type 3, Olivopontocerebellar Atrophy, Spinocerebellar Ataxia, and Drug Induced Dyskinesia. Dr. Paulson is board certified in Neurology.

Sharan Srinivasan is a Neurologist practicing medicine in Ann Arbor, Michigan. He has been practicing medicine for over 10 years. Dr. Srinivasan is rated as a Distinguished provider by MediFind in the treatment of Spinocerebellar Ataxia Type 5. He is also highly rated in 108 other conditions, according to our data. His clinical expertise encompasses Hereditary Ataxia, Olivopontocerebellar Atrophy, Spinocerebellar Ataxia Type 4, and Spinocerebellar Ataxia Type 5. Dr. Srinivasan is board certified in Neurology.

Vikram Shakkottai is a Neurologist practicing medicine in Ann Arbor, Michigan. Dr. Shakkottai is rated as a Distinguished provider by MediFind in the treatment of Spinocerebellar Ataxia Type 5. He is also highly rated in 72 other conditions, according to our data. His clinical expertise encompasses Olivopontocerebellar Atrophy, Spinocerebellar Ataxia, Spinocerebellar Ataxia Type 1, and Drug Induced Dyskinesia.

Andrew Mundwiler is a Neuromusculoskeletal Medicine specialist and a Neurologist practicing medicine in Grand Rapids, Michigan. He has been practicing medicine for over 15 years. Dr. Mundwiler is rated as an Experienced provider by MediFind in the treatment of Spinocerebellar Ataxia Type 5. He is also highly rated in 7 other conditions, according to our data. His clinical expertise encompasses Spinal and Bulbar Muscular Atrophy, Spinal Muscular Atrophy Type 3, Amyotrophic Lateral Sclerosis (ALS or Lou Gehrig's Disease), and Spinal Muscular Atrophy (SMA). Dr. Mundwiler is board certified in American Board Of Psychiatry And Neurology. Dr. Mundwiler is currently accepting new patients.

Peter K. Todd, M.D., Ph.D., is an assistant professor in the Department of Neurology in the University of Michigan Medical School.Dr. Todd earned his Bachelor of Science degree in 1994 from the University of California, San Diego. He then entered the Medical Science Training Program at the University of Wisconsin at Madison, where he completed his doctorate in 2002 and medical degree in 2004. His Ph.D research focused on synaptic defects in Fragile X Syndrome, a common inherited cause of cognitive impairment in children.He completed his internship and residency at the Hospital of the University of Pennsylvania in Philadelphia. While there, he did research on the role of the ubiquitin proteasome system and autophagy in Spinal and Bulbar Muscular Atrophy, a polyglutamine disorder, and Fragile X Tremor Ataxia Syndrome (FXTAS). He came to the U-M in 2008 for a clinical and research fellowship in movement disorders and neurogenetics.Todd joined the U-M faculty in 2010 as an assistant professor in movement disorders and neurogenetics, working in the laboratory of Henry L. Paulson, M.D., Ph.D., in the Center for Neurodegenerative Research.His current research is focused on the mechanisms underlying RNA-mediated neurodegeneration in FXTAS and myotonic dystrophy, and how these mechanisms may overlap and inform our understanding of other neurodegenerative disorders. He also sees patients with movement disorders and inherited neurological disease.Dr. Todd has received several academic awards, including a Howard Hughes Undergraduate Research Fellowship, the Francis M. Forester Prize for promise as an academic neurologist, the Samuel Ziritzky Prize for most outstanding research by a neurology resident at Penn and prizes for excellence in research at the International Conference on Unstable Microsatellites in Human Disease, and the U-M neuroscience day. Most recently, Dr Todd received the S. Weir Mitchell Alliance award from the American Academy of Neurology which each year recognizes one early investigator physician scientist who has made important contributions to basic science in neurological disorders.A member of the American Medical Association and the American Academy of Neurology, he has served as an ad-hoc reviewer for the Journal of Biological Chemistry, Neurology, Proceedings of the National Academy of Sciences, Neuron, Science and Human Molecular Genetics.His bibliography includes several peer-reviewed papers, editorials, book reviews and chapters, abstracts and online. Dr. Todd is rated as an Experienced provider by MediFind in the treatment of Spinocerebellar Ataxia Type 5. He is also highly rated in 49 other conditions, according to our data. His clinical expertise encompasses Fragile X Syndrome, Fragile XE Syndrome, Hereditary Ataxia, and Amyotrophic Lateral Sclerosis (ALS or Lou Gehrig's Disease). Dr. Todd is board certified in Neurology.

Richard Hammond is a Neurologist and a Sleep Medicine provider practicing medicine in Escanaba, Michigan. Dr. Hammond is rated as an Experienced provider by MediFind in the treatment of Spinocerebellar Ataxia Type 5. He is also highly rated in 59 other conditions, according to our data. His clinical expertise encompasses Memory Loss, Benign Essential Blepharospasm, Dravet Syndrome, and Autosomal Dominant Partial Epilepsy with Auditory Features. Dr. Hammond is board certified in American Board Of Psychiatry And Neurology.

Kenneth Gallmore is a primary care provider, practicing in Internal Medicine in Farmington Hills, Michigan. He has been practicing medicine for over 29 years. Dr. Gallmore is rated as an Experienced provider by MediFind in the treatment of Spinocerebellar Ataxia Type 5. He is also highly rated in 21 other conditions, according to our data. His clinical expertise encompasses Apoplexy, Heart Attack, Anemia, Gastrostomy, and Endoscopy. Dr. Gallmore is board certified in American Board Of Internal Medicine and American Osteopathic Board Of Internal Medicine.

John K. Fink, MD, is a professor in the Department of Neurology and director of the Neurogenetic Disorders Program in the University of Michigan Medical School. He directs basic science laboratory research focused on identifying genes and mechanisms responsible for age-dependent neurologic degeneration; and on developing treatments for these conditions.Fink's laboratory investigates the molecular basis of inherited neurologic and psychiatric disorders. His clinical expertise focuses on inherited and degenerative disorders of the nervous system. Dr. Fink evaluates individuals of all ages, from infancy through senescence with these disorders, which include lysosomal storage disorders (such as Gaucher disease, Niemann-Pick disease and Fabry disease), ataxias (including Friedreich's ataxia), leukodystrophies (such as Krabbe, CADASIL and adrenoleukodystrophy), familial dystonia, primary lateral sclerosis, Wilson's disease, familial motor neuron disease (including familial amyotrophic lateral sclerosis), familial dementia, and a group of inherited spinal cord disorders known collectively as the Hereditary Spastic Paraplegias (HSPs).Dr. Fink came to the University of Michigan in 1990 as an assistant professor of neurology and director of the Neurogenetic Disorders Clinic. The program provides care and evaluation for individuals and families with inherited and degenerative neurologic disorders; and clinical and molecular laboratory training for physicians and scientists studying these disorders. He was promoted to associate professor in 1996 and professor in 2005.Board-certified in neurology and medical genetics, Dr. Fink received his medical degree in 1980 from the Medical College of Ohio in Toledo. Following internship at the Mayo Clinic in Rochester, Minnesota, he completed a neurology residency in 1984 at the University of Virginia in Charlottesville. Subsequently, he trained in developmental and metabolic neurology and medical genetics at the National Institutes of Health.Dr. Fink has served as the Medical Advisor to the Spastic Paraplegia Foundation since its establishment (2002), and serves as ad hoc reviewer for numerous journals and NIH study sections.A member of the American Society of Human Genetics, American Academy of Neurology, American Neurological Association and the American College of Genetics, Dr. Fink received the Derek Denny-Brown Neurological Scholar Award from the American Neurological Association in 2002. In addition, he has been elected by peers to Best Doctors in America annually since 2001. Dr. Fink is rated as an Experienced provider by MediFind in the treatment of Spinocerebellar Ataxia Type 5. He is also highly rated in 45 other conditions, according to our data. His clinical expertise encompasses Spastic Paraplegia Type 7, Spastic Paraplegia Type 2, Primary Lateral Sclerosis, and CACH Syndrome. Dr. Fink is board certified in Clinical Genetics and Neurology.

Pratik Bhattacharya is a Neurologist practicing medicine in Pontiac, Michigan. Dr. Bhattacharya is rated as an Experienced provider by MediFind in the treatment of Spinocerebellar Ataxia Type 5. He is also highly rated in 20 other conditions, according to our data. His clinical expertise encompasses Stroke, Migraine with Brainstem Aura, Peripheral Neuropathy, Stent Placement, and Thrombectomy.

Richard Kovar is a Neuromusculoskeletal Medicine specialist and a Holistic Medicine provider practicing medicine in Fort Gratiot, Michigan. Mr. Kovar is rated as an Experienced provider by MediFind in the treatment of Spinocerebellar Ataxia Type 5. He is also highly rated in 29 other conditions, according to our data. His clinical expertise encompasses Tension Headache, Memory Loss, Seizures, and Migraine.

Scott Gutowski is a primary care provider, practicing in Family Medicine in Jonesville, Michigan. Dr. Gutowski is rated as an Experienced provider by MediFind in the treatment of Spinocerebellar Ataxia Type 5. His clinical expertise encompasses Maturity Onset Diabetes of the Young, Familial Hypertension, Hypertension, and Glucocorticoid-Remediable Aldosteronism.

Aryaan Khan is a Neurologist practicing medicine in Grand Rapids, Michigan. Dr. Khan is rated as an Experienced provider by MediFind in the treatment of Spinocerebellar Ataxia Type 5. He is also highly rated in 1 other condition, according to our data. His clinical expertise encompasses Spinocerebellar Ataxia Type 1, Spinocerebellar Ataxia Type 4, Spinocerebellar Ataxia Type 5, and Olivopontocerebellar Atrophy.

Ghazanfar Latif is a primary care provider, practicing in Internal Medicine in Saginaw, Michigan. Dr. Latif is rated as an Experienced provider by MediFind in the treatment of Spinocerebellar Ataxia Type 5. He is also highly rated in 12 other conditions, according to our data. His clinical expertise encompasses Glucocorticoid-Remediable Aldosteronism, Familial Hypertension, Hypertension, and High Cholesterol.

Edwin George is a Neurologist practicing medicine in Detroit, Michigan. Dr. George is rated as an Experienced provider by MediFind in the treatment of Spinocerebellar Ataxia Type 5. He is also highly rated in 24 other conditions, according to our data. His clinical expertise encompasses Stiff Person Syndrome, Movement Disorders, Parkinson's Disease, and Drug Induced Dyskinesia.

David Albrecht is a primary care provider, practicing in Internal Medicine in Wyoming, Michigan. Dr. Albrecht is rated as an Experienced provider by MediFind in the treatment of Spinocerebellar Ataxia Type 5. He is also highly rated in 36 other conditions, according to our data. His clinical expertise encompasses Type 2 Diabetes (T2D), Hypertensive Heart Disease, Maturity Onset Diabetes of the Young, and Ringworm.

Darla Wheeler is a Neurologist practicing medicine in Ann Arbor, Michigan. Dr. Wheeler is rated as an Experienced provider by MediFind in the treatment of Spinocerebellar Ataxia Type 5. She is also highly rated in 1 other condition, according to our data. Her clinical expertise encompasses Spinocerebellar Ataxia Type 8, Spinocerebellar Ataxia Type 4, Spinocerebellar Ataxia Type 5, and Olivopontocerebellar Atrophy.